NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $211,000 | -84.9% | 337,188 | -87.2% | 0.00% | – |
| Q3 2020 | $1,396,000 | -23.0% | 2,631,585 | -0.6% | 0.00% | -100.0% |
| Q2 2020 | $1,813,000 | -6.7% | 2,647,219 | +2.1% | 0.00% | 0.0% |
| Q1 2020 | $1,944,000 | -49.7% | 2,592,072 | +1.3% | 0.00% | 0.0% |
| Q4 2019 | $3,865,000 | +7.8% | 2,559,374 | +5.6% | 0.00% | 0.0% |
| Q3 2019 | $3,587,000 | +13.9% | 2,423,515 | -0.7% | 0.00% | 0.0% |
| Q2 2019 | $3,149,000 | -2.2% | 2,441,181 | +97.8% | 0.00% | 0.0% |
| Q1 2019 | $3,221,000 | +456.3% | 1,234,014 | +251.9% | 0.00% | – |
| Q4 2018 | $579,000 | +283.4% | 350,690 | +1029.3% | 0.00% | – |
| Q3 2018 | $151,000 | -62.1% | 31,054 | -51.2% | 0.00% | – |
| Q2 2018 | $398,000 | +44.7% | 63,628 | +92.0% | 0.00% | – |
| Q1 2018 | $275,000 | -24.5% | 33,135 | -7.0% | 0.00% | – |
| Q4 2017 | $364,000 | +267.7% | 35,641 | +136.1% | 0.00% | – |
| Q3 2016 | $99,000 | -10.0% | 15,094 | +26.8% | 0.00% | – |
| Q2 2016 | $110,000 | -51.5% | 11,905 | +10.0% | 0.00% | – |
| Q3 2015 | $227,000 | – | 10,820 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|